Work

Is lipoprotein-associated phospholipase A₂ correlated with cardiovascular risk in European women?

Year: 2013
Type: article
Abstract: Lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) is an enzyme expressed in atherosclerotic plaques by inflammatory cells; thus, its measurement could contribute to the identification of patients with ruptureprone plaques 1 .Lp-PLA 2 is carried in the blood stream by low density lipoprotein (LDL) particles, where it is bound to small cholesterol-deplete LDL particles rather than to large cholesterol-enriched LDL particles.As the Lp-PLA 2 -LDL complex enters the vessel wall, the reduced phospholipid content of smaller LDL particles increases the oxidative susceptibility of those particles 1 .Among the serum markers of inflammation, the Lp-PLA 2 is correlated with the progression, extension, and severity of cardiovascular disease (CVD) as well as to a greater mortality risk after coronary heart attack 2 .In fact, Lp-PLA 2 has been recommended as an inflammatory marker for CVD risk assessment in patients with moderate or high risk based on Framingham criteria 3 .However, in a large study of individuals without known CVD, the addition of Lp-PLA 2 information to the risk scores containing total cholesterol and HDL-C led to only slight improvement in CVD prediction 4 .
Author: V Hirschler
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2145954309
FWCI: 0.194
Cites: 11
Cited by: 1
Related to: 10